Latest Breaking News On - Deborah rathjen phd - Page 1 : comparemela.com

Carina Biotech Doses First Patient in Phase 1/2a Clinical Trial of LGR5-Targeted CAR-T Cell Therapy

Carina Biotech Doses First Patient in Phase 1/2a Clinical Trial of LGR5-Targeted CAR-T Cell Therapy
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

South australiaMichael brownStephanie carringtonDeborah rathjenJose iglesiasRudi michelsonMonsoon communicationsCarina biotech limitedBiotech doses first patientClinical trialBiotech limitedNew drugBayesian optimal intervalRecommended phaseDeborah rathjen phdChief executive

Carina Biotech Doses First Patient in Phase 1/2a Clinical

First patient dosed in Australia where 3 clinical trial sites have been activated.The trial will enrol advanced colorectal cancer patients whose cancer.

South australiaRudi michelsonDeborah rathjenMichael brownStephanie carringtonJose iglesiasCarina biotech limitedMonsoon communicationsBiotech limitedNew drugBayesian optimal intervalRecommended phaseDeborah rathjen phdChief executiveChief medical officer dr jose iglesiasPrincipal investigator

Bioasis Technologies Inc Announces Merger with Midatech Pharma plc

Bioasis Technologies Inc Announces Merger with Midatech Pharma plc
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesUnited kingdomSimon turtonMario saltarelliDeborah rathjenStephen parkerMidatech pharmaBiodexa pharmaceuticalsLawson lundellGraeme dickcolwell capital corpBoard of directors bioasis technologies incSupreme courtLadenburg thalmann coBioasis technologies incEvans incVenture exchange